ATS Governance

HomeAboutATS Governance ▶ ATS Leadership
ATS Leadership

Lynn Schnapp, MD

Lynn Schnapp, MD, ATSF, originally elected in 2018, will serve as the President.

Dr. Schnapp is the George R. and Elaine Love professor and chair of the Department of Medicine at the University of Wisconsin School of Medicine and Public Health. She is a faculty member in the division of Allergy, Pulmonary and Critical Care Medicine.

2021 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Schnapp has participated in research studies supported by BMS and Ironwood, with funding received by her institution. She has contributed to publications of Springer and UpToDate, with payments from Springer received directly and payments from UpToDate received by her institution. Her ongoing supported research is focused on understanding the roles of pericytes in the immune response and fibrotic response in the lung.

 

Gregory P. Downey

Gregory Downey, MD, ATSF, originally elected in 2019, will serve as the President-Elect. Dr. Downey will serve as President in 2022-2023.

Dr. Downey is a professor of medicine, pediatrics, and biomedical research at National Jewish Health where he also serves as executive vice president of Academic Affairs, and provost. He is also professor of medicine and immunology and microbiology and associate dean of the School of Medicine, at the University of Colorado in Denver.

2021 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Downey has served on the Board of Directors of the Lovelace Respiratory Institute and as a consultant for Angion in the development of novel anti-fibrotic compounds. No payments have been received from Angion. He previously served as a consultant for Biomotiv in the development of novel anti-inflammatory compounds.

 

M. Patricia Rivera

M. Patricia Rivera, MD, ATSF, originally elected in 2020, will serve as the Vice President. Dr. Rivera will serve as President in 2023-2024.

Dr. Rivera is a professor of medicine in the Division of Pulmonary Diseases and Critical Care Medicine at the University of North Carolina at Chapel Hill. In 1995, she joined the faculty at UNC and co-founded the first Multidisciplinary Thoracic Oncology Program in the country, a premier program that became the model for multidisciplinary care and defined the vital role pulmonologists play in the care of patients with thoracic malignancies. More recently, she founded the Multidisciplinary Lung Cancer Screening Program at UNC, and she continues to direct both programs.

2021 Disclosure of Potential Conflicts of Interest Relevant to ATS Activities: Dr. Rivera conducts research supported by the National Institutes of Health focused on comorbidity and functional status of persons undergoing lung cancer screening.

 

 Irina Petrache, MD, ATSF

Irina Petrache, MD, ATSF elected by the membership this past April, commences her term on the EC and will serve as the Secretary-Treasurer. Dr. Petrache will serve as President in 2024-2025.

Dr. Petrache is a professor of medicine at National Jewish Health, where she has served as the chief of the Division of Pulmonary, Critical Care and Sleep Medicine since 2015. She also holds an appointment as professor in the Department of Medicine and the Pharmacology Graduate Program, University of Colorado, Denver.

2021 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Petrache is a scientific co-founder of Allinaire Therapeutics which develops novel therapeutics for pulmonary arterial hypertension (PAH) and other pulmonary diseases, including EMAP II. She has conducted research supported by Allinaire, which evolved from work that Dr. Petrache and colleagues did as part of the University of Indiana Center for Biomedical Innovation and is funded by Biomotiv. She has participated in National Institutes of Health-supported research on sphingolipids and the effect of vaping on lung parenchyma.

 

Juan C. Celedón, MD, DrPH

Juan C. Celedón, MD, DrPH, ATSF, originally elected in 2017, will serve as the Immediate Past President. Dr. Celedón served as President in 2020-2021.

Dr. Celedón is the Niels K. Jerne Professor of Pediatrics and Medicine, and chief of the Division of Pediatric Pulmonary Medicine at the University of Pittsburgh School of Medicine.

2021 Disclosure of Potential Conflicts of Interests Relevant to ATS Activities: Dr. Celedón has participated in research studies supported by Merck and supported by the National Institutes of Health, with primary research goals of identifying genetic and environmental determinants of airway diseases, particularly in racial and ethnic minorities.